RQHTF (Reliq Health Technologies) Research & Development: $2.25 Mil (TTM As of Sep. 2022)


RQHTF Reliq Health Technologies Inc RQHTF
10 GF Score
Price $0.01
View Full Analysis

What is Reliq Health Technologies Research & Development?

Reliq Health Technologies RQHTF -99.99% 10 Research & Development is $2.25 Mil as of Sep. 2022. GuruFocus rates RQHTF with a GF Score™ of 10/100.

Research & Development is the aggregate amount of research and development expenses during the year. Reliq Health Technologies's Research & Development for the three months ended in Sep. 2022 was $0.60 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2022 was $2.25 Mil.

Reliq Health Technologies  (OTCPK:RQHTF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Reliq Health Technologies Research & Development Related Terms

Reliq Health Technologies Research & Development Historical Data

* Premium members only.

The historical data trend for Reliq Health Technologies's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Reliq Health Technologies Research & Development Chart

Reliq Health Technologies Annual Data
Trend Dec13 Dec14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.08 3.88 1.27 1.42 1.74

Reliq Health Technologies Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.10 0.31 0.83 0.51 0.60
RQHTF
10GF Score
Reliq Health Technologies Inc RQHTF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Reliq Health Technologies Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $2.25 Mil mean?
Reliq Health Technologies (RQHTF) has a Research & Development of $2.25 Mil as of Sep. 2022. Research and development expense is the total cost for research and development activities. View historical data on Reliq Health Technologies and its competitors.
Is Reliq Health Technologies' Research & Development too high?
Reliq Health Technologies' current Research & Development is $2.25 Mil. Overall, Reliq Health Technologies has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Reliq Health Technologies' Research & Development compare to VEEV and GEHC?
Reliq Health Technologies' Research & Development of $2.25 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Reliq Health Technologies and its competitors. Reliq Health Technologies's current Research & Development is $2.25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Reliq Health Technologies stock overvalued right now?
Reliq Health Technologies (RQHTF) has a current Research & Development of $2.25 Mil. The current Research & Development is $2.25 Mil. Reliq Health Technologies' overall GF Score™ is 10/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Reliq Health Technologies (RQHTF), the current Research & Development is $2.25 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Reliq Health Technologies Business Description

Address 175 Longwood Rd S., Suite 406A, Hamilton, ON, CAN, L8P 0A1
Reliq Health Technologies Inc specializes in developing Software-as-a-Service (SaaS) solutions for remote patient monitoring, telemedicine, and care collaboration. The company's IUGO health technology platform is a hardware and software solution that allows complex patients to receive high-quality care in the home, improving health outcomes, enhancing the quality of life for patients and families and reducing the cost of care delivery.
10GF Score

Get the complete analysis for RQHTF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.01
Price